QSP Summit 

May 20-21, 2020
MIT Samberg Conference Center | 50 Memorial Dr, Cambridge, MA 02142

Register

About the Event

qsp summit

The Quantitative Systems Pharmacology (QSP) Summit is an annual meeting dedicated to fostering an active community of industry and academic participants interested in topics relevant to QSP. In its fourth year, the QSP Summit is a free, two-day event featuring talks from key industry and academic researchers, a poster session with awards, and networking time with peers. 

Call for Abstracts

Abstract submission is open to all undergraduate, graduate, postdoctoral, industry (biotechs and pharma) faculty and staff in any computational biology field, including: quantitative biology, bioinformatics, applied mathematics, biochemistry, biophysics, biomedical engineering, electrical engineering, and chemical engineering. Abstracts will be selected for either a speaking presentation or poster. 

In addition, cash prizes will be awarded to the top three student, graduate student, and postdoc posters, with first place receiving $500, second place receiving $350, and third place receiving $200. 

Submit an Abstract

poster session

 

Speakers

Subject to change. 

  • Lindsay Avery, PhD, Principal Scientist, Sanofi
  • Yougan Cheng, PhD, Senior Research Investigator, Bristol-Myers Squibb
  • Panagiota Foteinou, PhD, Principal QSP Scientist, Sanofi
  • Kevin Galinsky, PhD, Senior Principal Statistician, Takeda
  • Sergio Iadevaia, PhD, Scientific Director; QSP, Pharmacometrics and Data Analysis, Takeda
  • Chanchala Kaddi, PhD, Senior Modeler, Bill & Melinda Gates Medical Research Institute
  • Lin Lin, PhD, Senior Scientist, Pharmacometrics, Biogen
  • Kathryn Miller-Jensen, PhD, Associate Professor of Biomedical Engineering, Yale University
  • Tatiana Novobrantseva, PhD, Co-founder and Chief Scientific Officer, Verseau Therapeutics
  • Ken Ogasawara, PhD, Principal Scientist, Clinical Pharmacology, Bristol-Myers Squibb
  • Michael Rosenblatt, MD, Chief Medical Officer, Flagship Pioneering
  • Anna Sher, PhD, Principal Scientist, Pfizer
  • Samuel Isaacson, PhD, Associate Professor of Mathematics and Statistics, Boston University
  • Theresa Yuraszeck, PhD, Associate Director, CSL Behring
  • Bo Zheng, PhD, Associate Director, Clinical Pharmacology, CSL Behring
  • Simon Zhou, PhD, Executive Director, Clinical Pharmacology and Translational Development, Bristol-Myers Squibb 

 

Agenda

Subject to change. 

09:00 AM 

Registration and breakfast

09:30 AM

John Burke, PhD
Co-Founder, President & CEO, Applied BioMath

Opening remarks

09:45 AM

Michael Rosenblatt, MD
Chief Medical Officer, Flagship Pioneering

10:15 AM

Samuel Isaacson, PhD
Associate Professor of Mathematics and Statistics, Boston University

10:45 AM

Break and poster viewing session

11:45 AM

Sergio Iadevaia, PhD
Scientific Director, QSP, Pharmacometrics and Data Analysis, Takeda 

12:15 PM

Kathryn Miller-Jensen, PhD
Associate Professor of Biomedical Engineering, Yale University

12:45 PM

Lunch and poster viewing session

02:15 PM

Panagiota Foteinou, PhD
Principal QSP Scientist, Sanofi

02:45 PM

Lightning talks

03:15 PM

Break and poster viewing session

04:15 PM

Lindsay Avery, PhD
Principal Scientist, Sanofi

04:45 PM

Yougan Cheng, PhD
Senior Research Investigator, Bristol-Myers Squibb

05:00 PM

Coffee and tea break

05:15 PM

Theresa Yuraszeck, PhD
Associate Director, CSL Behring

Bo Zheng, PhD
Associate Director, Clinical Pharmacology, CSL Behring

05:45 PM

Closing remarks - Day 1 concludes

 

09:00 AM 

Registration and breakfast

09:30 AM

John Burke, PhD
Co-Founder, President & CEO, Applied BioMath

Opening remarks

09:45 AM

Lin Lin, PhD
Senior Scientist, Pharmacometrics, Biogen

10:15 AM

Simon Zhou, PhD
Executive Director, Clinical Pharmacology and Translational Development, Bristol-Myers Squibb

Ken Ogasawara, PhD
Principal Scientist, Clinical Pharmacology, Bristol-Myers Squibb

10:45 AM

Break and poster viewing session

11:45 AM

Chanchala Kaddi, PhD
Senior Modeler, Bill & Melinda Gates Medical Research Institute

12:15 PM

Kevin Galinsky, PhD
Senior Principal Statistician, Takeda

12:45 PM

Lunch and poster awards

01:45 PM

Anna Sher, PhD
Principal Scientist, Pfizer

02:15 PM

Tatiana Novobrantseva, PhD
Co-founder and Chief Scientific Officer, Verseau Therapetuics

02:45 PM

Closing remarks - Day 2 concludes

 

 

Register

 

Questions?

Contact Renee at rfisher@appliedbiomath.com.